These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 27855391)

  • 1. Suppression of MicroRNA-219-5p Activates Keratinocyte Growth Factor to Mitigate Severity of Experimental Cirrhosis.
    Chen L; Cui X; Li P; Feng C; Wang L; Wang H; Zhou X; Yang B; Lv F; Li T
    Cell Physiol Biochem; 2016; 40(1-2):253-262. PubMed ID: 27855391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human umbilical cord mesenchymal stem cells ameliorate experimental cirrhosis through activation of keratinocyte growth factor by suppressing microRNA-199.
    Bi ZM; Zhou QF; Geng Y; Zhang HM
    Eur Rev Med Pharmacol Sci; 2016 Dec; 20(23):4905-4912. PubMed ID: 27981544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-22 Suppresses BMP7 in the Development of Cirrhosis.
    Ji D; Li B; Shao Q; Li F; Li Z; Chen G
    Cell Physiol Biochem; 2015; 36(3):1026-36. PubMed ID: 26112332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrogenic Signaling Is Suppressed in Hepatic Stellate Cells through Targeting of Connective Tissue Growth Factor (CCN2) by Cellular or Exosomal MicroRNA-199a-5p.
    Chen L; Chen R; Velazquez VM; Brigstock DR
    Am J Pathol; 2016 Nov; 186(11):2921-2933. PubMed ID: 27662798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-194 inactivates hepatic stellate cells and alleviates liver fibrosis by inhibiting AKT2.
    Wu JC; Chen R; Luo X; Li ZH; Luo SZ; Xu MY
    World J Gastroenterol; 2019 Aug; 25(31):4468-4480. PubMed ID: 31496625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteopontin promotes collagen I synthesis in hepatic stellate cells by miRNA-129-5p inhibition.
    Chen Y; Ou Y; Dong J; Yang G; Zeng Z; Liu Y; Liu B; Li W; He X; Lan T
    Exp Cell Res; 2018 Jan; 362(2):343-348. PubMed ID: 29196165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mouse Anxa6/miR-9-5p/Anxa2 axis modulates TGF-β1-induced mouse hepatic stellate cell (mHSC) activation and CCl
    Liao J; Zhang Z; Yuan Q; Luo L; Hu X
    Toxicol Lett; 2022 Jun; 362():38-49. PubMed ID: 35483553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-9a-5p regulates proliferation and migration of hepatic stellate cells under pressure through inhibition of Sirt1.
    Qi F; Hu JF; Liu BH; Wu CQ; Yu HY; Yao DK; Zhu L
    World J Gastroenterol; 2015 Sep; 21(34):9900-15. PubMed ID: 26379395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-125a-5p Contributes to Hepatic Stellate Cell Activation through Targeting FIH1.
    Li G; Li J; Li C; Qi H; Dong P; Zheng J; Yu F
    Cell Physiol Biochem; 2016; 38(4):1544-52. PubMed ID: 27074047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-17-5p-activated Wnt/β-catenin pathway contributes to the progression of liver fibrosis.
    Yu F; Lu Z; Huang K; Wang X; Xu Z; Chen B; Dong P; Zheng J
    Oncotarget; 2016 Jan; 7(1):81-93. PubMed ID: 26637809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the miR-31/FIH1 pathway in TGF-β-induced liver fibrosis.
    Hu J; Chen C; Liu Q; Liu B; Song C; Zhu S; Wu C; Liu S; Yu H; Yao D; Kang J; Zhu L
    Clin Sci (Lond); 2015 Aug; 129(4):305-17. PubMed ID: 25728779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential regulated expression of keratinocyte growth factor and its receptor in experimental and human liver fibrosis.
    Otte JM; Schwenger M; Brunke G; Schmitz F; Otte C; Kiehne K; Kloehn S; Mönig H; Schmidt WE; Herzig KH
    Regul Pept; 2007 Dec; 144(1-3):82-90. PubMed ID: 17692400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-345-5p curbs hepatic stellate cell activation and liver fibrosis progression by suppressing hypoxia-inducible factor-1alpha expression.
    Wang P; Fang Y; Qiu J; Zhou Y; Wang Z; Jiang C
    Toxicol Lett; 2022 Nov; 370():42-52. PubMed ID: 36126797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway.
    Tu X; Zhang H; Zhang J; Zhao S; Zheng X; Zhang Z; Zhu J; Chen J; Dong L; Zang Y; Zhang J
    J Pathol; 2014 Sep; 234(1):46-59. PubMed ID: 24817606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-378 limits activation of hepatic stellate cells and liver fibrosis by suppressing Gli3 expression.
    Hyun J; Wang S; Kim J; Rao KM; Park SY; Chung I; Ha CS; Kim SW; Yun YH; Jung Y
    Nat Commun; 2016 Mar; 7():10993. PubMed ID: 27001906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PGE
    Brea R; Motiño O; Francés D; García-Monzón C; Vargas J; Fernández-Velasco M; Boscá L; Casado M; Martín-Sanz P; Agra N
    Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):325-337. PubMed ID: 29109031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-873-5p acts as an epigenetic regulator in early stages of liver fibrosis and cirrhosis.
    Fernández-Ramos D; Fernández-Tussy P; Lopitz-Otsoa F; Gutiérrez-de-Juan V; Navasa N; Barbier-Torres L; Zubiete-Franco I; Simón J; Fernández AF; Arbelaiz A; Aransay AM; Lavín JL; Beraza N; Perugorria MJ; Banales JM; Villa E; Fraga MF; Anguita J; Avila MA; Berasain C; Iruzibieta P; Crespo J; Lu SC; Varela-Rey M; Mato JM; Delgado TC; Martínez-Chantar ML
    Cell Death Dis; 2018 Sep; 9(10):958. PubMed ID: 30237481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-155 attenuates activation of hepatic stellate cell by simultaneously preventing EMT process and ERK1 signalling pathway.
    Dai W; Zhao J; Tang N; Zeng X; Wu K; Ye C; Shi J; Lu C; Ning B; Zhang J; Lin Y
    Liver Int; 2015 Apr; 35(4):1234-43. PubMed ID: 25142507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosomes derived from miR-181-5p-modified adipose-derived mesenchymal stem cells prevent liver fibrosis via autophagy activation.
    Qu Y; Zhang Q; Cai X; Li F; Ma Z; Xu M; Lu L
    J Cell Mol Med; 2017 Oct; 21(10):2491-2502. PubMed ID: 28382720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of platelet-derived growth factor-C and insulin-like growth factor I in hepatic stellate cells is inhibited by miR-29.
    Kwiecinski M; Elfimova N; Noetel A; Töx U; Steffen HM; Hacker U; Nischt R; Dienes HP; Odenthal M
    Lab Invest; 2012 Jul; 92(7):978-87. PubMed ID: 22565577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.